J. Jill Inc. Common Stock (JILL)
StalwartFairStock Score: 56/100 — STEADY
Key Financials
| Current Price | $12.02 |
| Market Cap | $195M |
| P/E Ratio | 6.6 |
| ROE | 24.55% |
| Dividend Yield | 2.6% |
| Sector | Consumer Cyclical |
Strengths
- Generates $16 million in annual free cash flow (8.0% yield on market cap)
- High return on equity of 24.6% demonstrating efficient capital deployment
- Attractive 2.5% dividend yield providing steady income returns
Concerns
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Revenue declining at 3.1% year-over-year signals potential demand weakness or market share loss
- Weak Piotroski F-Score of 2/9 suggests deteriorating financial quality across multiple dimensions
- Altman Z-Score of 0.4 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
J. Jill Inc. Common Stock is a micro-cap consumer cyclical company valued at $195 million. Revenue stands at $597 million, though the company is currently unprofitable. From a quality standpoint, J. shows weak Piotroski F-Score of 2/9 signaling deteriorating fundamentals and distressed Altman Z-Score of 0.4 warrants caution. On valuation, the stock is deeply undervalued on a P/E basis at 7.2x, with a modest 28% margin of safety vs Graham Number. Growth dynamics show revenue growing at -3.1% and profit growth of -256.6%. The 2.5% dividend yield adds an income component for patient holders. Our composite FairStock Score of 56/100 reflects mixed fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
The market underappreciates J.'s consistent 25% ROE at just 7x earnings—a re-rating toward sector peers could unlock 30-50% upside. With $16 million in annual free cash flow (8.0% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer